L5. Monoclonal Antibody & Phage Display Lab
³æ®è§ÜÅé¤Î¾½µßÅé§e²{¹êÅç«Ç

¹êÅç«Ç¥D«ù¤H¡G³\¸UªK
¦@¦P¥D«ù¤H¡G­J¤p´@
 


 

­I´º¤Î³]¥ß½t¥Ñ

­I´º¸ê®Æ
³]¥ß½t¥Ñ
²{¦³°ò¦
°õ¦æ¤è®×
»P¨ä¥L­p¹º¤§¤¬°Ê
¹w´Áµ²ªG»P¦¨®Ä

 

ªA°È¤â¥U

³]¸m­I´º»P½t¥Ñ
³W¹º¤Î¯S¦â
¥Ó½ÐªA°È¶·ª¾

 
 
 
 


­I´º¸ê®Æ

°ò¦]©w§Ç¸Ñ½X«á¬°¤F¸Ñ·sµo²{°ò¦]ªºªí²{»P§_¡A ¨Ã¬ã¨s¨ä¥\¯à¡A¤@¶µ¤£¥i©Î¯Êªº¬ã¨s¤u¨ã´N¬O¨ã³Æ§Ü­ì±M¤@©Êªº§ÜÅé¡F±M¤@©Ê§ÜÅé¥i¥Ñ (1) ¤H¤u¦X¦¨¤§peptide §@¬°§Ü­ì²£¥Íªº¨ã³æ¤@©Ê¤§¶Ç²Î¦h®è§ÜÅé¡Apolyclonal antibody¡F(2) ³æ®è§ÜÅé¡Amonoclonal antibody¡F(3) ¾½µßÅé§e²{§ÜÅ骺¤è¦¡²£¥Í¡Aphage display¡C¨ä¤¤¡A²Ä¤@ºØ»s³Æ¤è¦¡¸û¬°®e©ö¡A¦Ó«á¨â¶µªº§Þ³N¼h¦¸¸û°ª¡A±M¤@©Ê±j¡A¥Ø«e¥»®Ö¤ß¹êÅç«Ç¨C¦~¯à»s³Æ¤Q¾lºØ³æ¤@©Ê¶Ç²Î§ÜÅé¡A¶i¦æ¤­¦¸¥ª¥kªº¿Ä¦X½F (Hybridoma) ¹êÅç¡A ¤Î§Q¥Î¾½µßÅé§e²{¤è¦¡¨M©w§Ü­ì¨M©w°Ï¡A¹w´Á³nµwÅéÂX¼W«á¾Þ§@®e¶q±N¼W¥[¨â­¿¡A¨ÃÀÀ±N³¡¤À³æ®è§ÜÅ餧»s³Æ¥H¾½µßÅé§ÜÅé¨ú¥N¡A¥H¥R¤À¤ä´© S1 ¤Î S3 ¬ã¨s©Ò»Ý¡C
³]¥ß½t¥Ñ
  1. ·sµo²{°ò¦]»Ý½á¤©¥\¯à©Ê¨¤¦â¡A¤~¦³¹ê½è·N¸q¡A¬G°£¤F³¡¥÷½Õ±±¤Îµ²ºc³J¥Õ½èªº°ò¦]¥~¡A¨ä¥L·s¨ã³Æ±M¤@©Êªº§ÜÅé¬OÃÒ¹ê³J¥Õ½è¯u¥¿ªí²{¤Î²Ó­M¤À¥¬ªº³Ì¨Î§Q¾¹¡C
  2. ²v¤ÎÂÇ¥H±a°Êµo®i¬ÛÃö·s§Þ³N¡C
  3. ÀËÅç¸Õ¾¯¤¤À³¥Îªº§ÜÅé¬O¤@¶µ«D±`­«­nªº¥Íª«§Þ³N²£«~¡Aµo²{­«­nªº°ò¦]«á¡A¥²¶·¶i¦Ó¤ÀªR¨ä³J¥Õ½è²£ª«¡A¦Ó³oÃþ«¬ªºÀ³¥Î¥²¶·°t¦X±M¤@©Êªº³æ®è§ÜÅé©Î¾½µßÅé§e²{§ÜÅ骺»s³Æ¡A¬G¥»®Ö¤ß¹êÅç«Çµo®i¤§¬ÛÃö§Þ³N±N¬O°ê¤º¥Íª«§Þ³N²£·~¤¤¤£¥i©Îªº¤@Àô¡C
  4. ÃĪ«ªº¶}µo¡A©Î´M§ä»P¤j¤À¤lµ²¦Xªºª«½è¤W§êºt­«­nªº¨¤¦â¡C
²{¦³°ò¦
¥Ø«e°ê¤º»s³Æ³æ®è§ÜÅé¥i§Q¥Î¨â®M¥Ñ°ê®a½Ã¥Í°|¸ê·½ºô¸ô©Ò´£¨Ñªº§K¶OªA°È¡A¦¹¥~¡A¥»®Ö¤ß¹êÅç«Ç¤]¦Û¦æ»s³Æ½èÅé¡A¨ä°ò¦]²£ª«¤§¦X¦¨¥Ñ¤@ CMV promoter ÅX°Ê¡A¥t¦b -N ºÝ±a¦³¤@­Ó epitope¡F¦Ó¿ë»{¸Ó epitope ©Ò»Ýªº³æ®è§ÜÅé·~¤w»s³Æ§¹¦¨¡A¸Ó³æ®è§ÜÅé¯à°µ¦è¤èÂI¾¥¤ÏÀ³ (Western blotting)¡B§K¬Ì¿Ã¥ú¬V¦â (Immuno-fluorescence staining)¡B§K¬Ì¨H¾ý¤ÏÀ³ (Immunoprecipitation) µ¥§K¬Ì¤ÀªR¹êÅç¡A¨Ã¤w°w¹ï¨âºØ¤£¦P¯f·½³J¥Õ§¹¦¨´ú¸Õ¡C¦P®É¡A¥H¾½µßÅé§e²{¤è¦¡¨M©w§Ü­ì¨M©w°Ï¤w¬O¥Ø«e¥»®Ö¤ß¹êÅç«Çªº±`³W©Êªº¾Þ§@¡C
°õ¦æ¤è®×
¬ã¨s¤ÎªA°È¥Ø¼Ð:
  1. »s³Æ¤Î§ïµ½¥Ø«e¨Ï¥Î¤§½èÅé¡CÄ´¦p¡A§Ú­Ì±N¦b½èÅ餺 ¢Ñ ºÝ¥[¤J¥t¤@­Ó§ÜÅé¼Ð¥Ü¡A¥H«K¦b·s°ò¦]³J¥Õ²£ª«¤§§ÜÅé©|¥¼»s³Æ¥X¨Ó¤§«e¡A§Y¥i§â DNA ¤ù¬q©ñ¤J½èÅ餺¡A¦b²Ó­M¤¤ªí²{«á¡A¥H²{¦³ªº¨âºØ§ÜÅé¤@«e¤@«á°»´ú¡C
  2. ¦b±M¤@©Ê§ÜÅé»s³y¤è­±¡A¥¼¨Ó¤@¦~¥b´Á¶¡¡A§Ú­Ì±N»s³Æ¬ù 20 ºØ³æ¤@¯S©Êªº¨ß¤l§ÜÅé¡A³o¨Ç§ÜÅ餧§Ü­ì§¡¿ï¦Û·sµo²{ªº¨xÀù²Õ´¤¤ªí²{¯S®í°ò¦]¡A¦P®É¡A§Ú­Ì±N¨Ì¾Ú²Ö¿nªº¬ÛÃö¹êÅçµ²ªG¡A¬D¥X¤G¦Ü¤T­Ó§Ü­ì¶i¦æ³æ®è§ÜÅé»s³Æ¡Cð
  3. µo®i¾½µßÅé§ÜÅé¡A»s³Æ·sªº¾½µßÅé§e²{ peptide library¡C
·s¼W»ö¾¹
  1. Quixell cell selection and transfer system, Manufactured by Stoelting¡C
  2. ¦¹³]³Æ¤§¥D­n¥\¯à¬°³æ¤@²Ó­Mªº¯Â¤Æ¡C¿Ä¦X½Fªº¦¨¥\»P§_ºÝ¿à©ó³æ®è¤Æªº¹Lµ{¤¤¬O§_¨³³t±o¨ìí©wªº²Ó­M®è¡A³q±`²Ä¤@¦¸¿z¿ï¶§©Ê¦ý¦bcloning limiting dilution «á¥¢¥h¤F¡A³q±`¶§©Ê cell culture wells ªº²Ó­M¦h¦ý±Ú¸s¨Ã¤£Âø¡F Quixell cell ¥i¥HÀ°§U±q³o¨Ç¶§©Ê¤§ cell culture wells ¤¤¬D¥X±Ú¸s¥Nªí©Êªº²Ó­M¡A´£°ª¦¨¥\²v¡C
  3. ¿Ã¥úÅã·LÃè¡G¤j³W¼Ò¤§°ò¦]Åé­pµe¶}©l«á¡A²{¦³¤§¿Ã¥úÅã·LÃè±N¤£¼Å¨Ï¥Î¡C
ªÅ¶¡
²{¦³¤Î¼WÁʤ§³]³Æ±N¦s©ñ©ó°ê¥ß¶§©ú¤j¾Ç¶Ç²ÎÂå¾Ç¤A´É¤j¼Ó¥|¼Ó¤§ 449 ¤Î 427 ²Õ´°ö¾i¬ã¨s«Ç¡C
¤H­û
¨C¦~±N¹µ¥Î±`¥ô§U²z¤@¦W¡C
¸g¶O¦ôºâ


»P¨ä¥L­p¹º¤§¤¬°Ê

¥»®Ö¤ß¹êÅç«Ç±N¤ä´©­p¹º¤¤±M¤@©Ê§ÜÅ骺»s³Æ¡A³o¨Ç§ÜÅé¦b¨M©w°ò¦]²£ª«ªº¥\¯à¤ÀªR®É¬O¤£¥i©Î¯Êªº¤u¨ã¡A¥¦¥iÀ°§U¨M©w°ò¦]©Ò§@¥Xªº³J¥Õ½è¦b²Ó­M¦s¦bªº¦ì¸m¡Bªí²{®É´Á¡B³J¥Õ½è¶¡¤¬¬Û§@¥Î©Î³J¥Õ½è»P®Ö»Äªº§@¥Î¡C¥»­p¹º±N¤ä´© S1 ¬ã¨s·s°ò¦]ªº¥\¯à¤Îªí²{¡A¨Ã°t¦X S2 ¿ï©wªº³J¥Õ²£ª«»s³Æ§ÜÅé¡A¾½µßÅé§e²{ peptide library ¥i»P S5 ¦@¦P§Q¥Î¡A¨Ã»P C2¡BL3¡BL6 ¤¬ °Ê ¦p ¤U ¡G
C2 (Gene Expression Analysis Center)
S1 ©Ò±o¸ê®Æ¸g C3 ¤ÀªR±o¨ì¥i¯à¦³·N¸qªºµ²ªG®É¡A¥»¹êÅç«Ç§Y¥i±N¨ä cDNA ¸Ë¤J§Ú­Ì¸Ë¦³³æ®è§ÜÅé¼Ð¥Üªº½èÅé¡A¥H»s³Æ³æ¤@©Ê§ÜÅé¡A¥Î¨ÓÀË´ú³o­Ó°ò¦]¦b²Ó­M¤¤ªí²{ªº¯S©Ê¡C
L3 (Molecular Pathology Lab)
°w¹ï S1 ¬ã¨sªº¯S®í°ò¦]¸s¡A¥»¹êÅç«Ç±N»s³Æ§ÜÅé¡A´£¨Ñ L3 °µ²Õ´¤Á¤ù¬V¦â¡A±´°Q¨ä»P¯e¯f¤§¶¡ªºÃö«Y¡C
L6 (Yeast Genetics Lab)
¥Ñ»Ã¥Àµß¨t²Î©ÒÆ[¹î¨ì³J¥Õ½è¤§¶¡ªº§@¥Î¡A¶·¶i¤@¨B¥H¥Í¤Æ¡A¤À¤l¥Íª«©Î¨ä¥L¹êÅç¤è¦¡¥[¥HÃÒ¹ê¡A¥»¹êÅç«Ç»s³Æªº§ÜÅé¥i¥H´£¨Ñ§K¬Ì¨H¾ý©Î§K¬Ì¿Ã¥úªº¤ÀªR¡C°£¦¹¤§¥~¡A¥»¹êÅç«Ç¥ç±NÄ~Äò´£¨Ñ±`¥Îªº³æ®è§ÜÅé¤Î½èÅéµ¹°ê¤ºªº¾Ç³N¬ã¨s³æ¦ì¡A¨Ã¨ó§U¶i¦æ¯S¥Î§ÜÅ骺»s³Æ¡C


¹w´Áµ²ªG»P¦¨®Ä

»P±Ð¨|½Òµ{¤è­±ªº°t¦X¤W¡A¥»¹êÅç«Ç±N¤ä´©²Ó­M¥Íª«¾Ç¤Îµo¨|¥Íª«¾Ç½Òµ{¤¤¥H±M¤@©Ê§ÜÅé§@²Ó­M¿Ã¥ú¬V¦â¡A©Î²Õ´§K¬Ì¿Ã¥ú¬V¦â¡A¨ó§U¤F¸Ñ¥Íª«µo¥Í¡B¦¨ªøªº¶iµ{¤¤³J¥Õ½èªí²{¤Î²¾°Êªº±¡§Î¡C¦bµ²ºc¥Íª«¾Ç¤W¡A§ÜÅé¤T«×ªÅ¶¡ªº¯S§Oµ²ºc¡B¤Î§Ü­ì¨M©wÂIªº¯S®íºc³y¡A¬°±Ð¾Ç¤Wªº¨}¦n±Ð§÷¡A¥t¥~¡A¦b¤À¤lÂå¾Ç¤Î¥Íª«§Þ³Nªº½Òµ{¤W¡A³æ®è§ÜÅé¤Î·s¿³ªº¾½µßÅé§e²{¤´¬O­«­nªº½ÒÃD¡A¥»¹êÅç«Ç¥i¤ä´©¬ÛÃöªº½Òµ{¡C

³]¸m­I´º»P½t¥Ñ

°ò¦]©w§Ç¸Ñ½X«á¬°¤F¸Ñ·sµo²{°ò¦]ªºªí²{»P§_¡A ¨Ã¬ã¨s¨ä¥\¯à¡A¤@¶µ¤£¥i©Î¯Êªº¬ã¨s¤u¨ã´N¬O¨ã³Æ§Ü­ì±M¤@©Êªº§ÜÅé¡F±M¤@©Ê§ÜÅé¥i¥Ñ (1) ¤H¤u¦X¦¨¤§ peptide §@¬°§Ü­ì²£¥Íªº¨ã³æ¤@©Ê¤§¶Ç²Î¦h®è§ÜÅé¡Apolyclonal antibody¡F(2) ³æ®è§ÜÅé¡Amonoclonal antibody¡F(3) ¾½µßÅé§e²{§ÜÅ骺¤è¦¡²£¥Í¡Aphage display¡C¨ä¤¤¡A²Ä¤@ºØ»s³Æ¤è¦¡¸û¬°®e©ö¡A¦Ó«á¨â¶µªº§Þ³N¼h¦¸¸û°ª¡A±M¤@©Ê±j¡A¥Ø«e¥»®Ö¤ß¹êÅç«Ç¨C¦~¯à»s³Æ¤Q¾lºØ³æ¤@©Ê¶Ç²Î§ÜÅé¡A¶i¦æ¤­¦¸¥ª¥kªº¿Ä¦X½F (Hybridoma) ¹êÅç¡A ¤Î§Q¥Î¾½µßÅé§e²{¤è¦¡¨M©w§Ü­ì¨M©w°Ï¡A¹w´Á³nµwÅéÂX¼W«á¡A¾Þ§@®e¶q±N¤£¨ü¾Ç¥Í§ó´À¦ÓµLªk±µÄò¡A¨ÃÀÀ±N³¡¤À³æ®è§ÜÅ餧»s³Æ¥H¾½µßÅé§ÜÅé¨ú¥N¡A¥H¥R¤À¤ä´© ¨xŦ¯fÅÜ¡B¨xŦ²Ó­M¥Íªø¡B²Ó­M¤À¤Æ¡Bµo¨|¡B¦Ñ¤Æ¡B¦Ñ¤Æ«á²£¥Í¬ÛÃöªº¯e¯f¡B¬ÛÃöÃĪ«ªº¶}µoµ¥¬ã¨s©Ò»Ý¡C¨Ã´£¨Ñ±Ð¨|°V½m½Òµ{¡]¯S§O¬O¡i¤À¤lÂå¾Ç¡j¤Î¡i¥Íª«§Þ³N¾Çµ{¡j¡^±Ð¾Ç¹ê²ß¡]Á¿²ß¯Z¡^©Ò»Ý¡C
  1. ·sµo²{°ò¦]»Ý½á¤©¥\¯à©Ê¨¤¦â¡A¤~¦³¹ê½è·N¸q¡A¬G°£¤F³¡¥÷½Õ±±¤Îµ²ºc³J¥Õ½èªº°ò¦]¥~¡A¨ä¥L·s°ò¦]©Ò¹ïÀ³ªº³J¥Õ½è²£ª«¨ä¯u¥¿ªºªí²{µ{«×¤Î²Ó­M¤º¤§¤À¥¬À³¤©¶i¤@³¡¤ÀªR¡C
  2. ¨ã³Æ±M¤@©Êªº§ÜÅé¬OÃÒ¹ê³J¥Õ½è¯u¥¿ªí²{¤Î²Ó­M¤À¥¬ªº³Ì¨Î§Q¾¹¡C
  3. ¦³Ãö»s³Æ³æ®è§ÜÅé¤Î¾½µßÅé§e²{§ÜÅ骺¦b§Þ³N¼h¦¸¸û°ª¡A ¥²¶·¸g¥Ñ¸gÅ礧²Ö¿n¡A©l¯à´£¤É¾Þ§@®Ä²v¤ÎÂÇ¥H±a°Êµo®i¬ÛÃö·s§Þ³N¡C
  4. ÀËÅç¸Õ¾¯¤¤À³¥Îªº§ÜÅé¬O¤@¶µ«D±`­«­nªº¥Íª«§Þ³N²£«~¡Aµo²{­«­nªº°ò¦]«á¡A¥²¶·¶i¦Ó¤ÀªR¨ä³J¥Õ½è²£ª«¡A¦Ó³oÃþ«¬ªºÀ³¥Î¥²¶·°t¦X±M¤@©Êªº³æ®è§ÜÅé©Î¾½µßÅé§e²{§ÜÅ骺»s³Æ¡A¬G¥»®Ö¤ß¹êÅç«Çµo®i¤§¬ÛÃö§Þ³N±N¬O°ê¤º¥Íª«§Þ³N²£·~¤¤¤£¥i©Îªº¤@Àô¡C
  5. ¾½µßÅé§e²{§Þ³N¤wÁͦ¨¼ô¡A¤£¶È¥i»s³Æ§ÜÅé¥N´Àª«¡A¨Ã¥i§e²{·¥µuªº peptide library¡A³oÃþ§Þ³N¦bÃĪ«ªº¶}µo¡A©Î´M§ä»P¤j¤À¤lµ²¦Xªºª«½è¤W§êºt­«­nªº¨¤¦â¡C
²{¦³°ò¦
¥Ø«e°ê¤º»s³Æ³æ®è§ÜÅé¨Ï¥Î¤W¥i§Q¥Î°ê®a½Ã¥Í°|¸ê·½ºô¸ô©Ò´£¨ÑªA°È¡A¦¹¥~¡A¥»®Ö¤ß¹êÅç«Ç¤]¦Û¦æ»s³Æ½èÅé¡A¨ä°ò¦]²£ª«¤§¦X¦¨¥Ñ¤@ CMV promoter ÅX°Ê¡A¥t¦b -N ºÝ±a¦³¤@­Ó epitope¡AC ºÝ±a¦³¥t¤@ epitope¡F¦Ó¿ë»{¸Ó epitope ©Ò»Ýªº³æ®è§ÜÅé·~¤w»s³Æ§¹¦¨¡A¸Ó³æ®è§ÜÅé¯à°µ¦è¤èÂI¾¥¤ÏÀ³¡]Western blotting¡^¡B§K¬Ì¿Ã¥ú¬V¦â¡]Immuno-fluorescence staining¡^¡B§K¬Ì¨H¾ý¤ÏÀ³¡]Immunoprecipiotation¡^µ¥§K¬Ì¤ÀªR¹êÅç¡A±N°w¹ï¦UºØ¤£¦P¨Ó·½³J¥Õ¶i¦æ´ú¸Õ¡C¦P®É¡A±N¥H¾½µßÅé§e²{¤è¦¡¨M©w§Ü­ì¨M©w°Ï³]¬°¥»®Ö¤ß¹êÅç«Çªº±`³W©Êªº¾Þ§@¡C
¬ã¨s¤ÎªA°È¥Ø¼Ð
  1. »s³Æ¤Î§ïµ½¥Ø«e¨Ï¥Î¤§½èÅé¡CÄ´¦p¡A§Ú­Ì¤w¦b½èÅ餺 ¢Ñ ºÝ¥[¤J¥t¤@­Ó§ÜÅé¼Ð¥Ü¡A¥H«K¦b·s°ò¦]³J¥Õ²£ª«¤§§ÜÅé©|¥¼»s³Æ¥X¨Ó¤§«e¡A§Y¥i§â DNA ¤ù¬q©ñ¤J½èÅ餺¡A¦b²Ó­M¤¤ªí²{«á¡A¥H²{¦³ªº¨âºØ§ÜÅé¤@«e¤@«á°»´ú¡C¦] ¬°³J¥Õ½è©Ê½è¤£¦P¡A¤£¦Pªí²{ªº½èÅé±`·|¦³¤£¦Pªº®ÄªG¡A¦]¦¹§Ú­Ì±N»s³Æ¤Î§ï¶i³o¨Ç½èÅé¡C
  2. ¦b±M¤@©Ê§ÜÅé»s³y¤è­±¡A¥¼¨Ó¨C¤@¦~¡A§Ú­Ì±N»s³Æ¬ù 10-15 ºØ³æ¤@¯S©Êªº¨ß¤l§ÜÅé¡A³o¨Ç§ÜÅ餧§Ü­ì§¡¿ï¦Û·sµo²{ªº¨xÀù²Õ´¤¤ªí²{¯S®í°ò¦]¡A¦P®É¡A±N¨Ì¾Ú²Ö¿nªº¬ÛÃö¹êÅçµ²ªG¡A¸g«ÈÆ[µû¦ô«á¬D¥X¤G¦Ü¤T­Ó§Ü­ì¶i¦æ³æ®è§ÜÅé»s³Æ¡C¥»¹êÅç«Ç¤]´£¨Ñ®Õ¤º¦P¤¯±q¨Æ¥¦¶µ¬ã¨sªÌ§Þ³N¤ä´©»P¿Ô¸ß¡A­Y¦³¯S®í±¡§ÎªÌ¤]¥i¥H­Ó¤H¦X§@­pµe°Ñ»P¡C
  3. µo®i¾½µßÅé§ÜÅé¡A»s³Æ·sªº¾½µßÅé§e²{ peptide library¡C
³W¹º¤Î¯S¦â
 


¥Ó½ÐªA°È¶·ª¾
 

I. Polyclonal Antibody Preparation
V. ¥Ø«eªA°È¯à¶q
¨C¦~¼W¥[±`¥Î©Ê¡B¦@¦P©Ê°ªªº¦h®è§ÜÅé (peptide antibodies) ¨â®è¡AHybridoma fusion ¨â¦¸¡A°ò¥»ºû«ù¸g¶O¤Q¸U¤¸¡AªA°È¯à¶q¥i¥HÂX±i¦Ü¦h®è§ÜÅé¤QºØ¡AHybridoma fusion ¤­¦¸¡C
VI. «D±`³WªA°È¤§¦X§@¬ã¨s
  1. Recombinant protein construction and purification¡C
  2. Preparation of plasmids with eitope tagging¡C
VII. ¨ä¥Lª`·N¨Æ¶µ
Hybridoma screening ­Y±ý¥H¨ä¥L¤è¦¡¨ú¥N¡A¥²¶·¦b hybridoma fusion ¤§«e«Ø¥ß¡Ascreening ®Éµ{»P§xÃø«×¥ç¶·¥t¥~¦Ò¼{¡C
VIII. ­t³d±Ð±Â¤Î³sµ¸¤èªk
·L¥Íª«¤Î§K¬Ì¾Ç¬ã¨s©Ò¡@³\¸UªK ±Ð±Â
Phone: 28267112; Fax: 28212880
Email: wjsyu@ym.edu.tw

·L¥Íª«¤Î§K¬Ì¾Ç¬ã¨s©Ò  ­J¤p´@ ±Ð±Â
Phone:28267000 ext. 5622; Fax: 28212880
Email: tingnahu@ym.edu.tw

IX. §Þ³N°V½m¤Î±À¼s¬¡°Ê
¨C¦~²Ä¤G¾Ç´Á¶}½Ò¡a³æ®è§ÜÅé»P¾½µßÅé§e²{¡b¡A¨C¨â¦~¶}¿ì¤@¦¸¤u§@¬ã°Q·| (Phage Display Workshop)¡C